Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002007919-24-000042
Filing Date
2024-08-30
Accepted
2024-08-30 16:16:36
Documents
1
Period of Report
2024-08-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1725048989.html 4  
1 FORM 4 wk-form4_1725048989.xml 4 4141
  Complete submission text file 0002007919-24-000042.txt   5739
Mailing Address C/O HERON THERAPEUTICS, INC 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
MANHARD KIMBERLY (Reporting) CIK: 0001202094 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42031 | Film No.: 241270267

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Issuer) CIK: 0002007919 (see all company filings)

EIN.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)